ADAP
Price
$0.32
Change
+$0.01 (+3.23%)
Updated
Apr 3 closing price
Capitalization
84.53M
41 days until earnings call
ELEV
Price
$0.26
Change
-$0.00 (-0.00%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
15.31M
27 days until earnings call
Ad is loading...

ADAP vs ELEV

Header iconADAP vs ELEV Comparison
Open Charts ADAP vs ELEVBanner chart's image
Adaptimmune Therapeutics
Price$0.32
Change+$0.01 (+3.23%)
Volume$3.94M
Capitalization84.53M
Elevation Oncology
Price$0.26
Change-$0.00 (-0.00%)
Volume$79.37K
Capitalization15.31M
ADAP vs ELEV Comparison Chart
Loading...
ADAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADAP vs. ELEV commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAP is a Hold and ELEV is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ADAP: $0.32 vs. ELEV: $0.26)
Brand notoriety: ADAP and ELEV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAP: 211% vs. ELEV: 77%
Market capitalization -- ADAP: $84.53M vs. ELEV: $15.31M
ADAP [@Biotechnology] is valued at $84.53M. ELEV’s [@Biotechnology] market capitalization is $15.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAP’s FA Score shows that 0 FA rating(s) are green whileELEV’s FA Score has 1 green FA rating(s).

  • ADAP’s FA Score: 0 green, 5 red.
  • ELEV’s FA Score: 1 green, 4 red.
According to our system of comparison, ELEV is a better buy in the long-term than ADAP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAP’s TA Score shows that 4 TA indicator(s) are bullish while ELEV’s TA Score has 4 bullish TA indicator(s).

  • ADAP’s TA Score: 4 bullish, 4 bearish.
  • ELEV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ADAP and ELEV are a good buy in the short-term.

Price Growth

ADAP (@Biotechnology) experienced а +47.23% price change this week, while ELEV (@Biotechnology) price change was -0.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

ADAP is expected to report earnings on May 15, 2025.

ELEV is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADAP($84.5M) has a higher market cap than ELEV($15.3M). ADAP YTD gains are higher at: -39.874 vs. ELEV (-53.431). ELEV has higher annual earnings (EBITDA): -40.42M vs. ADAP (-55.9M). ADAP has more cash in the bank: 186M vs. ELEV (93.2M). ELEV has less debt than ADAP: ELEV (31.1M) vs ADAP (74.5M). ADAP has higher revenues than ELEV: ADAP (175M) vs ELEV (0).
ADAPELEVADAP / ELEV
Capitalization84.5M15.3M552%
EBITDA-55.9M-40.42M138%
Gain YTD-39.874-53.43175%
P/E RatioN/AN/A-
Revenue175M0-
Total Cash186M93.2M200%
Total Debt74.5M31.1M240%
FUNDAMENTALS RATINGS
ADAP: Fundamental Ratings
ADAP
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADAPELEV
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 23 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ADAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEVDQ0.02N/A
N/A
Nevada Copper Corp.
ALFVY41.71-1.08
-2.52%
Alfa-Laval AB
SOMMY11.50-0.59
-4.88%
Sumitomo Chemical Co., Ltd.
VTYX1.00-0.06
-5.66%
Ventyx Biosciences
KHNGY42.93-2.90
-6.32%
Kuehne & Nagel International AG

ELEV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELEV has been loosely correlated with TBPH. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ELEV jumps, then TBPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELEV
1D Price
Change %
ELEV100%
+5.86%
TBPH - ELEV
42%
Loosely correlated
-0.11%
ADAP - ELEV
32%
Poorly correlated
+22.00%
BOLT - ELEV
31%
Poorly correlated
+4.70%
AUTL - ELEV
30%
Poorly correlated
+11.35%
CLDX - ELEV
27%
Poorly correlated
+3.15%
More